Psilocybin therapy for treatment resistant depression | Imperial College London

Psilocybin therapy offers a transformative approach for individuals suffering from treatment-resistant depression where conventional antidepressants have failed. By combining psilocybin administration with psychological support, the therapy aims to facilitate profound emotional breakthroughs and neurological recalibration. Participants typically engage in preparation sessions before the active dosing session, followed by integration work to process the experience. This clinical model emphasizes the importance of setting and safety within a controlled environment to maximize therapeutic benefits and minimize adverse reactions. The research highlights the potential for creating lasting shifts in patient outlook and mood regulation by addressing deep-seated psychological patterns.